Galapagos NV

3.26% €27.88

17:30 – 17/10/2024

Nieuws van Galapagos NV

Galapagos receives transparency notification from EcoR1 Capital

Bron: GlobeNewswire

Autheur: Galapagos NV

Gepubliceerd op: 2024-09-16

Mechelen, Belgium; 16 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from EcoR1 Capital LLC.

Galapagos NV (NASDAQ:GLPG) Shares Bought by Headlands Technologies LLC

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-09-18

Headlands Technologies LLC raised its holdings in Galapagos NV (NASDAQ:GLPG – Free Report) by 56.7% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,233…

Galapagos NV (NASDAQ:GLPG) Shares Purchased by DME Capital Management LP

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-09-26

DME Capital Management LP increased its stake in shares of Galapagos NV (NASDAQ:GLPG – Free Report) by 46.9% in the 2nd quarter, Holdings Channel.com reports. The firm owned 234,828 shares of the biotechnology company’s stock after purchasing an additional 75…

Rhumbline Advisers Increases Position in Galapagos NV (NASDAQ:GLPG)

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-10-01

Rhumbline Advisers lifted its position in shares of Galapagos NV (NASDAQ:GLPG – Free Report) by 21.6% in the 2nd quarter, Holdings Channel.com reports. The firm owned 4,578 shares of the biotechnology company’s stock after purchasing an additional 814 shares …

Galapagos ontvangt transparantieverklaring van EcoR1 Capital

Bron: GlobeNewswire

Autheur: Galapagos NV

Gepubliceerd op: 2024-09-16

Mechelen, België; 16 september 2024, 22:01 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GLPG) heeft een kennisgeving van belangrijke deelneming ontvangen van EcoR1 Capital, LLC.

Renaissance Technologies LLC Buys 4,300 Shares of Galapagos NV (NASDAQ:GLPG)

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-09-26

Renaissance Technologies LLC raised its stake in shares of Galapagos NV (NASDAQ:GLPG – Free Report) by 1.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 270,800 sh…

Galapagos NV (NASDAQ:GLPG) Given Consensus Rating of “Reduce” by Analysts

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-10-05

Galapagos NV (NASDAQ:GLPG – Get Free Report) has been given an average rating of “Reduce” by the five ratings firms that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating and four have given a hold …

Galapagos NV (NASDAQ:GLPG) Receives Average Recommendation of “Reduce” from Analysts

Bron: Biztoc.com

Autheur: marketbeat.com

Gepubliceerd op: 2024-10-05

Shares of Galapagos NV (NASDAQ:GLPG – Get Free Report) have earned an average rating of “Reduce” from the five brokerages that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating and four have issued a hold…

Millennium Management LLC Boosts Position in Galapagos NV (NASDAQ:GLPG)

Bron: Biztoc.com

Autheur: marketbeat.com

Gepubliceerd op: 2024-10-10

Millennium Management LLC lifted its position in Galapagos NV (NASDAQ:GLPG – Free Report) by 5.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor ow…

Galapagos NV (NASDAQ:GLPG) Shares Bought by DME Capital Management LP

Bron: Biztoc.com

Autheur: marketbeat.com

Gepubliceerd op: 2024-09-26

DME Capital Management LP raised its stake in Galapagos NV (NASDAQ:GLPG – Free Report) by 46.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 234,828 shares of the biotechn…

Primecap Management Co. CA Increases Stock Position in Galapagos NV (NASDAQ:GLPG)

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-09-19

Primecap Management Co. CA raised its position in Galapagos NV (NASDAQ:GLPG – Free Report) by 0.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 720,240 shares of the b…

Stonepine Capital Management LLC Boosts Stock Holdings in Galapagos NV (NASDAQ:GLPG)

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-10-01

Stonepine Capital Management LLC boosted its holdings in shares of Galapagos NV (NASDAQ:GLPG – Free Report) by 23.2% during the second quarter, Holdings Channel reports. The firm owned 485,000 shares of the biotechnology company’s stock after acquiring an add…

Dimensional Fund Advisors LP Has $713,000 Position in Galapagos NV (NASDAQ:GLPG)

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-10-14

Dimensional Fund Advisors LP lowered its holdings in shares of Galapagos NV (NASDAQ:GLPG – Free Report) by 24.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional inves…

Galapagos (NASDAQ:GLPG) Shares Gap Up – Here’s What Happened

Bron: Biztoc.com

Autheur: marketbeat.com

Gepubliceerd op: 2024-10-07

Galapagos NV (NASDAQ:GLPG – Get Free Report)’s stock price gapped up before the market opened on Monday . The stock had previously closed at $29.19, but opened at $30.29. Galapagos shares last traded at $30.36, with a volume of 30,604 shares changing hands. A…

Galapagos verwelkomt Oleg Nodelman in haar Raad van Bestuur om strategische groei te ondersteunen

Bron: GlobeNewswire

Autheur: Galapagos NV

Gepubliceerd op: 2024-10-07

Mechelen, België; 7 oktober 2024, 7:00 CET – Galapagos NV (Euronext & NASDAQ: GLPG), kondigde vandaag de benoeming aan, via coöptatie, van Oleg Nodelman, als Niet-Uitvoerend, Niet-Onafhankelijk Bestuurder in haar Raad van Bestuur, met ingang van 7 oktober 202…

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

Bron: GlobeNewswire

Autheur: Galapagos NV

Gepubliceerd op: 2024-10-07

Mechelen, Belgium; October 7, 2024, 07:00 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced the appointment by way of co-optation of Oleg Nodelman as Non-Executive Non-Independent Director to its Board of Directors, effective October 7, 2024.

Galapagos NV (NASDAQ:GLPG) is Stonepine Capital Management LLC’s 4th Largest Position

Bron: Biztoc.com

Autheur: marketbeat.com

Gepubliceerd op: 2024-10-01

Stonepine Capital Management LLC grew its holdings in shares of Galapagos NV (NASDAQ:GLPG – Free Report) by 23.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 485,000 …

Head-To-Head Survey: Galapagos (NASDAQ:GLPG) & Adial Pharmaceuticals (NASDAQ:ADIL)

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-09-21

Adial Pharmaceuticals (NASDAQ:ADIL – Get Free Report) and Galapagos (NASDAQ:GLPG – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownersh…

Belgium stocks lower at close of trade; BEL 20 down 0.32%

Bron: Investing.com

Autheur: Investing.com

Gepubliceerd op: 2024-09-18

Belgium stocks lower at close of trade; BEL 20 down 0.32%

Belgium stocks higher at close of trade; BEL 20 up 0.13%

Bron: Investing.com

Autheur: Investing.com

Gepubliceerd op: 2024-09-24

Belgium stocks higher at close of trade; BEL 20 up 0.13%

Comparing Oxurion (OTCMKTS:TBGNF) and Mind Medicine (MindMed) (NASDAQ:MNMD)

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-10-09

Mind Medicine (MindMed) (NASDAQ:MNMD – Get Free Report) and Oxurion (OTCMKTS:TBGNF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, an…

Head-To-Head Analysis: Avalon GloboCare (NASDAQ:ALBT) & Gilead Sciences (NASDAQ:GILD)

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-09-18

Gilead Sciences (NASDAQ:GILD – Get Free Report) and Avalon GloboCare (NASDAQ:ALBT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnin…

Rheumatology Therapeutics Market Set to Expand from $40.45 Billion in 2023 to $51.42 Billion in 2028 – Global Long-term Forecast to 2033

Bron: GlobeNewswire

Autheur: Research and Markets

Gepubliceerd op: 2024-10-10

Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) — The “Rheumatology Therapeutics Market Report 2024” report has been added to ResearchAndMarkets.com’s offering. The global rheumatology therapeutics market has exhibited a robust growth pattern in recent history and is…

Critical Contrast: Gilead Sciences (NASDAQ:GILD) and HilleVax (NASDAQ:HLVX)

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-10-11

HilleVax (NASDAQ:HLVX – Get Free Report) and Gilead Sciences (NASDAQ:GILD – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, ear…

CAR-T Cell Therapy Market Research 2024: Regulatory Approvals, Pricing, Reimbursement, Degree of Market Penetration, Mergers and Acquisitions, IPOs, and Financing Events

Bron: GlobeNewswire

Autheur: Research and Markets

Gepubliceerd op: 2024-10-16

Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) — The “Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials, and Trends, 2024” report has been added to ResearchAndMarkets.com’s offering.

Gastrointestinal Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 386 Deals Signed Since 2016 by the World’s Leading Life Science Companies and Universities

Bron: GlobeNewswire

Autheur: Research and Markets

Gepubliceerd op: 2024-09-25

Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) — The “Gastrointestinal Collaboration and Licensing Deals 2016-2024” report has been added to ResearchAndMarkets.com’s offering.Fully revised and updated, the report provides details of 386 gastrointestinal deals from …

Scroll naar boven